BRISTOL MYERS SQUIBB FDA Approval NDA 050341

NDA 050341

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #050341

Application Sponsors

NDA 050341BRISTOL MYERS SQUIBB

Marketing Status

Discontinued003

Application Products

003SUSPENSION;ORAL100MG/ML0FUNGIZONEAMPHOTERICIN B

FDA Submissions

ORIG1AP1971-06-02
LABELING; LabelingSUPPL3AP1996-03-07
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1996-09-11
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1997-01-17

Submissions Property Types

ORIG1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50341
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"FUNGIZONE","activeIngredients":"AMPHOTERICIN B","strength":"100MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"FUNGIZONE","submission":"AMPHOTERICIN B","actionType":"100MG\/ML","submissionClassification":"SUSPENSION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.